Solid Biosciences Inc.
Company Stats
- Market Cap
- $775.2M
- as of Sep 30, 2026
- Shares Outstanding
- 107.2M
- Free Float
- 55.9%
Income Statement
- Operating Income
- -$179.2M
- Net Income
- -$174.3M
- EBITDA
- -$177.6M
Cash Flow
- Free Cash Flow
- -$157.4M
- FCF Yield
- -20.3%
- Owner FCF Yield
- -22.5%
Balance Sheet
- Cash & Equivalents
- $59.9M
Returns & Capital
- SBC, 3Y Avg
- $11.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$157.4M | — |
| FY2024 | — | -$100.7M | — |
| FY2023 | — | -$95.7M | — |
| FY2022 | $8.1M | -$101.0M | -1247.7% |
| FY2021 | $13.6M | -$79.0M | -580.4% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.